3',5'-cyclic-AMP phosphodiesterase
gene
reagent
sample publication
sample review
total:3
Phosphodiesterase 4 and phosphatase 2A differentially regulate cAMP/protein kinase a signaling for cardiac myocyte contraction under stimulation of beta1 adrenergic receptor. 2008 to the paper
Abcam anti-PDE4 antibody was used in western blot in order to study the role of PP2A in limiting PKA phosphorylation of phospholamban and TnI for myocyte contraction responses under beta1AR stimulation more
total:1
Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells. 2008 to the paper
FabGennix anti-PDE4C antibody was used in western blot to study the effects of longer term pre-treatment with a specific inhibitor of phosphodiesterase-4 (PDE4), on [Ca2+]i, cAMP levels, and PDE activity and expression in HUVEC.
total:1
Expression of the cAMP-phosphodiesterase PDE4D isoforms and age-related changes in follicle-stimulating hormone-stimulated PDE4 activities in immature rat sertoli cells. 2007 to the paper
Santa Cruz Biotechnology anti-PDE4D antibody was used in western blot to evaluate the cAMP response to FSH and the FSH-stimulated PDE activities in proliferating.